Cervical Cancer Recurrent or Persistent
1 clinical trials · Condition
◉ Watch Cervical Cancer Recurrent or Persistent
| Record | Firm | Date |
|---|---|---|
| Combination of Nimotuzumab Cisplatin-Vinorelbine in First Line Chemotherapy in Recurring-Persistent Cervical Carcinoma (NCT02083211) | National Institute of Cancerología | 2010-07-01 |
Track Cervical Cancer Recurrent or Persistent automatically
Every clearance here is in the API, with alerts when new ones post.